IJR vs XLV
iShares Core S&P Small-Cap ETF vs Health Care Select Sector SPDR Fund
- • IJR has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | IJR | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.11% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $111.32B | $40.60B |
YTD return | 20.11% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.08 | 0.51 |
P/E ratio | 19.01 | 29.12 |
Last price | $145.78 | $161.81 |
Inception | — | — |
Issuer | iShares | State Street |
IJR top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.08% |
| FORM | FormFactor Inc | 0.67% |
| VSAT | Viasat Inc | 0.66% |
| MOH | Molina Healthcare Inc | 0.64% |
| AGX | Argan Inc | 0.60% |
| BTSG | BrightSpring Health Services Inc | 0.60% |
| ESI | Element Solutions Inc | 0.59% |
| MXL | MaxLinear Inc | 0.58% |
| KRYS | Krystal Biotech Inc | 0.53% |
| ESE | ESCO Technologies Inc | 0.49% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About IJR
IJR (iShares Core S&P Small-Cap ETF) is Tracks the S&P SmallCap 600 index. Managed by iShares, the fund carries $111.3B in assets under management, an expense ratio of 0.06%, a dividend yield of 1.11%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 2.1% of the portfolio. Real Estate is the fund's largest sector exposure at 7.6%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.